Market Place
Sourcing Support
Mereo BioPharma To Participate In Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Mereo BioPharma Reports Q2 2024 Results And Corporate Update
13 Aug 2024 //
GLOBENEWSWIRE
Ultragenyx, Mereo`s brittle bone drug sustains fracture rate cut
13 Jun 2024 //
FIERCE BIOTECH
Mereo At Jefferies Healthcare Fireside Chat
30 May 2024 //
GLOBENEWSWIRE
Mereo BioPharma Reports Q1 2024 Financial Results, Corporate Update
15 May 2024 //
GLOBENEWSWIRE
Mereo Bio to Participate in Fireside Chat at the 23rd Annual Needham Conference
03 Apr 2024 //
GLOBENEWSWIRE
Mereo BioPharma Reports Full Year 2023 Financial Results
27 Mar 2024 //
GLOBENEWSWIRE
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
08 Jan 2024 //
GLOBENEWSWIRE
Mereo Bio Reports on Recent Program Developments and Provides Financial Update
23 Oct 2023 //
GLOBENEWSWIRE
Ultragenyx, Mereo`s bone disease med cuts fractures by 67%
16 Oct 2023 //
FIERCE BIOTECH
Mereo Bio to Participate in Fireside Chat at the 2023 Healthcare Conference
21 Sep 2023 //
GLOBENEWSWIRE
Mereo BioPharma to Present at the Jefferies Healthcare Conference
31 May 2023 //
GLOBENEWSWIRE
Phase 2 Data from ASTRAEUS Trial of Mereo BioPharma Alvelestat Presented
23 May 2023 //
GLOBENEWSWIRE
Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
08 May 2023 //
GLOBENEWSWIRE
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
05 May 2023 //
GLOBENEWSWIRE
Mereo to Participate in Fireside Chat at Annual Needham Healthcare Conference
13 Apr 2023 //
GLOBENEWSWIRE
Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights
28 Mar 2023 //
GLOBENEWSWIRE
Mereo BioPharma Provides Regulatory Updates on Alvelestat
21 Mar 2023 //
GLOBENEWSWIRE
Mereo to Participate in Fireside Chat at SVB Securities Biopharma Conference
08 Feb 2023 //
GLOBENEWSWIRE
Mereo to Participate in Fireside Chat at the Jefferies London Conference
08 Nov 2022 //
GLOBENEWSWIRE
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
28 Oct 2022 //
GLOBENEWSWIRE
After months of back and forth, Mereo and its biggest stockholder reach truce
28 Oct 2022 //
ENDPTS
Mereo gives in to investor demands, hands over board seats
28 Oct 2022 //
FIERCEBIOTECH
Mereo BioPharma to Host Alvelestat R&D Update Call on October 31, 2022
24 Oct 2022 //
GLOBENEWSWIRE
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
21 Oct 2022 //
GLOBENEWSWIRE
Rubric Capital Management Comments on Mereo BioPharma Updated Operating Plan
18 Oct 2022 //
BUSINESSWIRE
Mereo Cuts 40% of Staff to Drive Rare Disease Programs through the Clinic
18 Oct 2022 //
BIOSPACE
Mereo stock rises 12% on FDA fast-track status for lung disease drug alvelestat
17 Oct 2022 //
SEEKING ALPHA
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat
17 Oct 2022 //
GLOBENEWSWIRE
Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene
03 Oct 2022 //
GLOBENEWSWIRE
Rubric Increases Slate of Proposed Mereo BioPharma Director Nominees to Five
03 Oct 2022 //
BUSINESSWIRE
Rubik`s Cube not solved at Mereo as investor rejects biotech`s offer
26 Sep 2022 //
ENDPTS
Activist investor snaps Mereo`s olive branch as proxy feud looms
26 Sep 2022 //
FIERCEBIOTECH
Mereo BioPharma Reports Clinical & Interim Biomarker Analysis at ESMO 2022
12 Sep 2022 //
GLOBENEWSWIRE
Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
09 Sep 2022 //
GLOBENEWSWIRE
Mereo BioPharma Sends Letter to Rubric Capital Management
31 Aug 2022 //
MEREOBIOPHARMA
Mereo lays off employees, pushes back against lead stakeholder`s proposals
31 Aug 2022 //
ENDPTS
Mereo`s biggest shareholder eyes major changes amid stock falloff
22 Aug 2022 //
ENDPTS
Mereo BioPharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
05 Jul 2022 //
GLOBENEWSWIRE
Mereo BioPharma To Present Data for PIb/II Study of Etigilimab + Nivolumab
02 Jun 2022 //
GLOBENEWSWIRE
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
26 May 2022 //
GLOBENEWSWIRE
Mereo BioPharma to Present Updated Data From PI/II Study of Etigilimab
26 May 2022 //
GLOBENEWSWIRE
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
17 May 2022 //
GLOBENEWSWIRE
Mereo BioPharma’s Alvelestat Meets Endpoints in ASTRAEUS Trial in AATD
10 May 2022 //
TRIALSITENEWS
Mereo BioPharma to Participate in Fireside Chat at 21st Needham Conference
06 Apr 2022 //
GLOBENEWSWIRE
Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights
31 Mar 2022 //
GLOBENEWSWIRE
Mereo BioPharma to Hold Virtual R&D Day on Monday, March 14, 2022
03 Mar 2022 //
GLOBENEWSWIRE
Mereo BioPharma to Participate at 11th Annual SVB Leerink Conference
10 Feb 2022 //
GLOBENEWSWIRE
UAB &Mereo Announce Positive Top-line Results “COSTA” Ph1b/2 Trial of Alvelestat
22 Dec 2021 //
GLOBENEWSWIRE
Mereo BioPharma to Present at Two Upcoming Investor Conferences
09 Nov 2021 //
GLOBENEWSWIRE
Data from Investigator-sponsored Trial of Mereo BioPharma’s alvelestat in BOS
04 Nov 2021 //
GLOBENEWSWIRE
Mereo Receives U.S. Orphan Drug Designation for alvelestat in the Treatment
26 Oct 2021 //
GLOBENEWSWIRE
Mereo BioPharma, the Osteogenesis Imperfecta Federation Europe (OIFE)
13 Oct 2021 //
GLOBENEWSWIRE
Mereo BioPharma and Ultragenyx Present Data from the Ph2b ASTEROID of UX143
02 Oct 2021 //
GLOBENEWSWIRE
Mereo BioPharma and Ultragenyx Present Data from Ph2b ASTEROID Study of UX143
01 Oct 2021 //
GLOBENEWSWIRE
Mereo BioPharma Announces Appointment of Pierre Jacquet to Board of Directors
20 Sep 2021 //
GLOBENEWSWIRE
Mereo BioPharma to Participate in Fireside Chat at BTIG
02 Aug 2021 //
GLOBENEWSWIRE
Mereo and Cancer Focus Fund Announce Partnership for Phase 1b/2
30 Apr 2021 //
GLOBENEWSWIRE
Notice of AGM
16 Apr 2021 //
PRESS RELEASE
